Beximco Pharmaceuticals Limited Sponsored GDR RegS Financial Overview
Beximco Pharmaceuticals Limited Sponsored GDR RegS's market cap is currently 49.03B. The company's EPS TTM is p; its P/E ratio is 4.63; and it has a dividend yield of 4.81%. Beximco Pharmaceuticals Limited Sponsored GDR RegS is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.